A previous study reported that Pyk2 plays a central role in the migratory behavior of glioblastomas [72], and another study showed that Pyk2 promotes the migration and invasion of glioma cells and that the inhibition of Pyk2 attenuates glioma progression [73]. Here, PTK2B is linked to central nervous system cancer.